Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration.
Khurana RN, Kunimoto D, Yoon YH, Wykoff CC, Chang A, Maturi RK, Agostini H, Souied E, Chow DR, Lotery AJ, Ohji M, Bandello F, Belfort R Jr, Li XY, Jiao J, Le G, Kim K, Schmidt W, Hashad Y; CEDAR and SEQUOIA Study Groups.
Khurana RN, et al. Among authors: hashad y.
Ophthalmology. 2021 Jul;128(7):1027-1038. doi: 10.1016/j.ophtha.2020.11.017. Epub 2020 Nov 19.
Ophthalmology. 2021.
PMID: 33221326
Free article.
Clinical Trial.